{"disease":{"id":"cip","name":"cip"},"drugs":{"marketed":[{"drug_id":"atovaquone-and-proguanil","indication_name":"Prophylaxis of P. falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Atovaquone and Proguanil","company_name":"State University of New York - Upstate Medical University","drug_phase":"marketed","molecular_target":"","drug_class":"Antimalarial [EPC]","quality_score":40,"revenue":null,"mechanism":null},{"drug_id":"atovaquone-and-proguanil","indication_name":"Treatment of acute, uncomplicated P. falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Atovaquone and Proguanil","company_name":"State University of New York - Upstate Medical University","drug_phase":"marketed","molecular_target":"","drug_class":"Antimalarial [EPC]","quality_score":40,"revenue":null,"mechanism":null},{"drug_id":"fusidic-acid","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ramycin","generic_name":"FUSIDIC ACID","company_name":"","drug_phase":"phase_3","molecular_target":"Bile salt export pump","drug_class":"fusidic acid","quality_score":47,"revenue":null,"mechanism":"Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins."},{"drug_id":"artesunate","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Artesunate","generic_name":"ARTESUNATE","company_name":"Amivas","drug_phase":"marketed","molecular_target":"","drug_class":"artesunate","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"doxycyclin","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Doxycyclin","company_name":"Bulovka Hospital","drug_phase":"marketed","molecular_target":"72 kDa type IV collagenase, Stromelysin-1, Collagenase 3","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"hydroxychloroquine-pill","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"hydroxychloroquine-pill","company_name":"Sanofi","drug_phase":"discontinued","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":null,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and modulating the immune system to treat autoimmune diseases."},{"drug_id":"hydroxychloroquine-pill","indication_name":"Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"hydroxychloroquine-pill","company_name":"Sanofi","drug_phase":"discontinued","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":null,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and modulating the immune system to treat autoimmune diseases."},{"drug_id":"sulfafurazole","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Azo Gantrisin","generic_name":"sulfafurazole","company_name":"Alra","drug_phase":"marketed","molecular_target":"Endothelin-1 receptor","drug_class":"Sulfonamide Antimicrobial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"artemisinin","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Artemef","generic_name":"ARTEMISININ","company_name":"","drug_phase":"phase_3","molecular_target":"Cytochrome P450 1A2","drug_class":"artemisinin","quality_score":31,"revenue":null,"mechanism":"Artemef works by generating reactive oxygen species that rapidly kill malaria parasites."},{"drug_id":"lumefantrine","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Coartem","generic_name":"LUMEFANTRINE","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Potassium voltage-gated channel subfamily H member 2","drug_class":"Antimalarial [EPC]","quality_score":65,"revenue":null,"mechanism":"Coartem Tablets, a combination of artemether and lumefantrine, act as an antimalarial agent."},{"drug_id":"halofantrine","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Halfan","generic_name":"HALOFANTRINE","company_name":"GSK","drug_phase":"marketed","molecular_target":"Potassium voltage-gated channel subfamily H member 2","drug_class":"Antimalarial","quality_score":33,"revenue":null,"mechanism":""},{"drug_id":"arsuamoon","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Arsuamoon","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":7,"revenue":null,"mechanism":null},{"drug_id":"mefloquine","indication_name":"Chloroquine Resistant Plasmodium Falciparum Malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lariam","generic_name":"MEFLOQUINE","company_name":"","drug_phase":"marketed","molecular_target":"Adenosine receptor A2a","drug_class":"Antimalarial","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"mefloquine","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lariam","generic_name":"MEFLOQUINE","company_name":"","drug_phase":"marketed","molecular_target":"Adenosine receptor A2a","drug_class":"Antimalarial","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"chloroquine","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aralen","generic_name":"CHLOROQUINE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Sigma non-opioid intracellular receptor 1","drug_class":"Antimalarial","quality_score":65,"revenue":null,"mechanism":"Aralen works by accumulating in the acidic compartments of the malaria parasite, disrupting its metabolism and ultimately leading to its death."},{"drug_id":"chloroquine","indication_name":"Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aralen","generic_name":"CHLOROQUINE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Sigma non-opioid intracellular receptor 1","drug_class":"Antimalarial","quality_score":65,"revenue":null,"mechanism":"Aralen works by accumulating in the acidic compartments of the malaria parasite, disrupting its metabolism and ultimately leading to its death."},{"drug_id":"quinine","indication_name":"Chloroquine Resistant Plasmodium Falciparum Malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Qualaquin","generic_name":"QUININE","company_name":"Sun Pharm Industries","drug_phase":"marketed","molecular_target":"Sodium channel alpha subunits; brain (Types I, II, III)","drug_class":"Antimalarial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"quinine","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Qualaquin","generic_name":"QUININE","company_name":"Sun Pharm Industries","drug_phase":"marketed","molecular_target":"Sodium channel alpha subunits; brain (Types I, II, III)","drug_class":"Antimalarial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"hydroxychloroquine","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"HYDROXYCHLOROQUINE","company_name":"Advanz","drug_phase":"marketed","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":75,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and reducing inflammation in the body."},{"drug_id":"hydroxychloroquine","indication_name":"Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"HYDROXYCHLOROQUINE","company_name":"Advanz","drug_phase":"marketed","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":75,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and reducing inflammation in the body."},{"drug_id":"artesunate-amodiaquine-as-aq","indication_name":"Treatment of acute, uncomplicated Plasmodium falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"artesunate-amodiaquine (AS-AQ)","company_name":"Yale University","drug_phase":"marketed","molecular_target":"Plasmodium falciparum heme iron (Fe2+), parasite DNA, heme polymerase","drug_class":"Artemisinin derivative + aminoquinoline antimalarial combination","quality_score":22,"revenue":null,"mechanism":""},{"drug_id":"proguanil","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Malarone","generic_name":"PROGUANIL","company_name":"GSK","drug_phase":"marketed","molecular_target":"","drug_class":"Antimalarial [EPC]","quality_score":60,"revenue":null,"mechanism":"Malarone works by inhibiting the parasite's ability to synthesize nucleic acids, ultimately preventing its replication and spread within the body."},{"drug_id":"proguanil","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Malarone","generic_name":"PROGUANIL","company_name":"GSK","drug_phase":"marketed","molecular_target":"","drug_class":"Antimalarial [EPC]","quality_score":60,"revenue":null,"mechanism":"Malarone works by inhibiting the parasite's ability to synthesize nucleic acids, ultimately preventing its replication and spread within the body."},{"drug_id":"proguanil","indication_name":"Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Malarone","generic_name":"PROGUANIL","company_name":"GSK","drug_phase":"marketed","molecular_target":"","drug_class":"Antimalarial [EPC]","quality_score":60,"revenue":null,"mechanism":"Malarone works by inhibiting the parasite's ability to synthesize nucleic acids, ultimately preventing its replication and spread within the body."},{"drug_id":"artemether","indication_name":"Chloroquine Resistant Plasmodium Falciparum Malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Coartem","generic_name":"ARTEMETHER","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Antimalarial [EPC]","quality_score":10,"revenue":null,"mechanism":"Artemether works by rapidly killing malaria parasites in the blood and liver."},{"drug_id":"arterolane","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ARTEROLANE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"mefloquine-hydrochloride","indication_name":"Chloroquine Resistant Plasmodium Falciparum Malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lariam","generic_name":"MEFLOQUINE HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"Adenosine receptor A2a","drug_class":"Antimalarial","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"mefloquine-hydrochloride","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lariam","generic_name":"MEFLOQUINE HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"Adenosine receptor A2a","drug_class":"Antimalarial","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"atovaquone","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mepron","generic_name":"ATOVAQUONE","company_name":"","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2","drug_class":"Antimalarial [EPC]","quality_score":10,"revenue":null,"mechanism":"Mepron works by inhibiting the electron transport chain in the mitochondria of Plasmodium parasites, ultimately leading to their death."},{"drug_id":"atovaquone","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mepron","generic_name":"ATOVAQUONE","company_name":"","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2","drug_class":"Antimalarial [EPC]","quality_score":10,"revenue":null,"mechanism":"Mepron works by inhibiting the electron transport chain in the mitochondria of Plasmodium parasites, ultimately leading to their death."},{"drug_id":"atovaquone","indication_name":"Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mepron","generic_name":"ATOVAQUONE","company_name":"","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2","drug_class":"Antimalarial [EPC]","quality_score":10,"revenue":null,"mechanism":"Mepron works by inhibiting the electron transport chain in the mitochondria of Plasmodium parasites, ultimately leading to their death."},{"drug_id":"doxycycline","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vibramycin","generic_name":"doxycycline","company_name":"Generic (originally Pfizer)","drug_phase":"marketed","molecular_target":"72 kDa type IV collagenase, Stromelysin-1, Collagenase 3","drug_class":"Tetracycline antibiotic","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"hydroxychloroquin","indication_name":"Falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Hydroxychloroquin","company_name":"Children's Hospital of Fudan University","drug_phase":"marketed","molecular_target":"Transmembrane protein 97, Alpha-1D adrenergic receptor, Alpha-2A adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"hydroxychloroquin","indication_name":"Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Hydroxychloroquin","company_name":"Children's Hospital of Fudan University","drug_phase":"marketed","molecular_target":"Transmembrane protein 97, Alpha-1D adrenergic receptor, Alpha-2A adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":34,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05348603","title":"Electronic Health Record Strategies to Promote Diverse Participation in Research","phase":"NA","overall_status":"COMPLETED","enrollment_count":726199,"lead_sponsor_name":"Yale University","has_results":false},{"nct_id":"NCT06467487","title":"Electronic Health Record Strategies to Promote Diverse Participation in Research AIM 2","phase":"NA","overall_status":"COMPLETED","enrollment_count":214526,"lead_sponsor_name":"Yale University","has_results":false},{"nct_id":"NCT03062085","title":"Shanghai High Myopia Study","phase":"","overall_status":"RECRUITING","enrollment_count":60000,"lead_sponsor_name":"Shanghai High Myopia Study Group","has_results":false},{"nct_id":"NCT05052502","title":"Targeting High Risk Populations With Enhanced Reactive Focal Mass Drug Administration in Thailand","phase":"NA","overall_status":"UNKNOWN","enrollment_count":49118,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT04505722","title":"A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":44325,"lead_sponsor_name":"Janssen Vaccines & Prevention B.V.","has_results":true},{"nct_id":"NCT03783299","title":"Targeted Active Case Detection Among High Risk Populations in Southern Lao Peoples Democratic Republic","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":39968,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT06870344","title":"IGHID 12334 - After the Flood: Optimal Strategies to Prevent Malaria Epidemics Caused by Severe Flooding","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":36000,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT06065852","title":"National Registry of Rare Kidney Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":35000,"lead_sponsor_name":"UK Kidney Association","has_results":false},{"nct_id":"NCT04614948","title":"A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":31835,"lead_sponsor_name":"Janssen Vaccines & Prevention B.V.","has_results":true},{"nct_id":"NCT04416945","title":"Targeting High Risk Populations With Enhanced Reactive Case Detection in Southern Lao Peoples Democratic Republic","phase":"NA","overall_status":"UNKNOWN","enrollment_count":31443,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT03806465","title":"Malaria Vaccine Pilot Evaluation","phase":"","overall_status":"COMPLETED","enrollment_count":30124,"lead_sponsor_name":"Rafiq OKINE","has_results":false},{"nct_id":"NCT05148806","title":"Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) Antibodies","phase":"","overall_status":"COMPLETED","enrollment_count":28411,"lead_sponsor_name":"Imperial College London","has_results":true},{"nct_id":"NCT05306067","title":"Plasmodium Falciparum Genomic Intelligence in Mozambique","phase":"","overall_status":"COMPLETED","enrollment_count":21848,"lead_sponsor_name":"Centro de Investigacao em Saude de Manhica","has_results":false},{"nct_id":"NCT06923592","title":"Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":19200,"lead_sponsor_name":"London School of Hygiene and Tropical Medicine","has_results":false},{"nct_id":"NCT06529237","title":"Malaria Molecular Surveillance in Mozambique (Phase 2)","phase":"","overall_status":"RECRUITING","enrollment_count":18750,"lead_sponsor_name":"Centro de Investigacao em Saude de Manhica","has_results":false},{"nct_id":"NCT04412005","title":"Pregnant Women for Malaria Surveillance","phase":"","overall_status":"COMPLETED","enrollment_count":16958,"lead_sponsor_name":"Barcelona Institute for Global Health","has_results":false},{"nct_id":"NCT07403318","title":"Mobile Health Supported Self-care Among Tertiary Education Students in Zimbabwe","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":16000,"lead_sponsor_name":"Liverpool School of Tropical Medicine","has_results":false},{"nct_id":"NCT04657783","title":"French National Cohort of People With Type 1 Diabetes","phase":"","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"Fondation Francophone pour la Recherche sur le Diabete","has_results":false},{"nct_id":"NCT05150808","title":"Vectron T500 (Broflanilide 50WP) for IRS in Tanzania Tanzania","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":12500,"lead_sponsor_name":"London School of Hygiene and Tropical Medicine","has_results":false},{"nct_id":"NCT02979457","title":"Degree of Worry as a Predictor for Utilization of Acute Health Care","phase":"NA","overall_status":"COMPLETED","enrollment_count":11340,"lead_sponsor_name":"University of Southern Denmark","has_results":false},{"nct_id":"NCT04839900","title":"Proactive Community Case Management for Malaria in Zambia","phase":"NA","overall_status":"COMPLETED","enrollment_count":10890,"lead_sponsor_name":"PATH","has_results":false},{"nct_id":"NCT04864444","title":"Mass Drug Administration of Dihydroartemisinin-piperaquine + Single Low-dose Primaquine to Accelerate Toward Elimination Activities","phase":"NA","overall_status":"COMPLETED","enrollment_count":10715,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT03063216","title":"Shanghai Pediatric Cataract Study","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Evidence Based Cataract Study Group","has_results":false},{"nct_id":"NCT06068530","title":"Mass Vaccine and Drug Administration, Bangladesh","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT07301853","title":"Longitudinal Follow-up and Health-Related Outcomes in Liver Transplant Recipients and Living Donors","phase":"","overall_status":"RECRUITING","enrollment_count":9999,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT05731102","title":"Diagnostic Survey of Mental and Substance Use Disorders Among Norwegian College and University Students","phase":"","overall_status":"COMPLETED","enrollment_count":9585,"lead_sponsor_name":"Norwegian Institute of Public Health","has_results":false},{"nct_id":"NCT07389057","title":"Assessing the Feasibility of Combining Dihydroartemisinin Piperaquine and Primaquine for Malaria Mass Drug Administration in High Endemic Communities in the Eastern Region of Ghana","phase":"NA","overall_status":"RECRUITING","enrollment_count":9000,"lead_sponsor_name":"Noguchi Memorial Institute for Medical Research","has_results":false},{"nct_id":"NCT03201770","title":"Cohort Event Monitoring Study of Pyramax®","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":8572,"lead_sponsor_name":"Shin Poong Pharmaceutical Co. Ltd.","has_results":false},{"nct_id":"NCT04897789","title":"The Early Head Start Family and Child Experiences Survey (Baby FACES 2018)","phase":"","overall_status":"UNKNOWN","enrollment_count":6723,"lead_sponsor_name":"Mathematica Policy Research, Inc.","has_results":false},{"nct_id":"NCT02448745","title":"Liberia Insecticide Treated Durable Wall Linings Study: Protocol for a Cluster Randomised Trial (DL)","phase":"NA","overall_status":"COMPLETED","enrollment_count":6317,"lead_sponsor_name":"The Mentor Initiative","has_results":false},{"nct_id":"NCT04348058","title":"Telephone Services for Participation in Colorectal Cancer Screening","phase":"NA","overall_status":"UNKNOWN","enrollment_count":6300,"lead_sponsor_name":"Maria Sklodowska-Curie National Research Institute of Oncology","has_results":false},{"nct_id":"NCT03143218","title":"Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":5920,"lead_sponsor_name":"London School of Hygiene and Tropical Medicine","has_results":true},{"nct_id":"NCT03971435","title":"Head Start Family and Child Experiences Survey (FACES 2019)","phase":"","overall_status":"COMPLETED","enrollment_count":5593,"lead_sponsor_name":"Mathematica Policy Research, Inc.","has_results":false},{"nct_id":"NCT04093765","title":"Mass Screening and Treatment for Reduction of Falciparum Malaria","phase":"NA","overall_status":"COMPLETED","enrollment_count":5542,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT06424002","title":"The Impact RTS,S/AS01 Vaccine in School Aged Children RTS,S/AS01 Malaria Vaccine in School Aged Children","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":5400,"lead_sponsor_name":"Kamuzu University of Health Sciences","has_results":false},{"nct_id":"NCT03529214","title":"An Evaluation of the Team Birth Project","phase":"NA","overall_status":"COMPLETED","enrollment_count":5217,"lead_sponsor_name":"Harvard School of Public Health (HSPH)","has_results":true},{"nct_id":"NCT03705377","title":"Head Start Family and Child Experiences Survey (FACES 2014)","phase":"","overall_status":"COMPLETED","enrollment_count":5193,"lead_sponsor_name":"Mathematica Policy Research, Inc.","has_results":false},{"nct_id":"NCT04319380","title":"Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ) Extension Study","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":5098,"lead_sponsor_name":"London School of Hygiene and Tropical Medicine","has_results":true},{"nct_id":"NCT06486402","title":"DISPARITY Study: An Observational Evaluation of Characteristics of Participants in Clinical Studies","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT00736749","title":"Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT06955351","title":"REsuscitation Survey of Police Officers in New Taipei City for Duty","phase":"","overall_status":"COMPLETED","enrollment_count":4867,"lead_sponsor_name":"Far Eastern Memorial Hospital","has_results":false},{"nct_id":"NCT06512740","title":"The 2021-2022 Study of Family and Staff Well-Being in Head Start FACES Programs","phase":"","overall_status":"COMPLETED","enrollment_count":4825,"lead_sponsor_name":"Mathematica Policy Research, Inc.","has_results":false},{"nct_id":"NCT04149106","title":"Seasonal Malaria Chemoprevention With Dihydroartemisin Piperaquin vs. Sulfadoxine-pyrimethamin+Amodiaquin","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":4556,"lead_sponsor_name":"University Clinical Research Center, Mali","has_results":false},{"nct_id":"NCT03745677","title":"Redesigning Systems to Improve Quality for Hospitalized Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":4265,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT04661228","title":"Diagnostic Survey of Mental and Substance Use Disorders in HUNT (PsykHUNT)","phase":"","overall_status":"COMPLETED","enrollment_count":4242,"lead_sponsor_name":"Norwegian Institute of Public Health","has_results":false},{"nct_id":"NCT07237971","title":"Cocreating Action to Improve Rationality in the Health System","phase":"NA","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"Universidad Miguel Hernandez de Elche","has_results":false},{"nct_id":"NCT00090220","title":"A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3819,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT06728995","title":"Renal Function Prediction in Living Donor Transplant Using Baseline Data","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3500,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT04800055","title":"Attractive Targeted Sugar Bait Phase III Trial in Zambia","phase":"NA","overall_status":"UNKNOWN","enrollment_count":3480,"lead_sponsor_name":"PATH","has_results":false},{"nct_id":"NCT04452318","title":"COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3303,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}